Licenses and Collaborations (Details Narrative) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||||
|---|---|---|---|---|---|---|
Jan. 02, 2019 |
Sep. 30, 2019 |
Sep. 30, 2018 |
Sep. 30, 2019 |
Sep. 30, 2018 |
Dec. 31, 2018 |
|
| Accounts receivable | $ 768 | $ 768 | ||||
| Revenue | 492 | 6,162 | ||||
| Merck Sharp & Dohme Corp [Member] | ||||||
| Due from related parties | 768 | 768 | ||||
| Collaboration Agreement [Member] | ||||||
| Proceeds from collaborators | $ 4,000 | |||||
| Accounts receivable | 4,368 | |||||
| Milestone upfront payment | 4,000 | |||||
| Revenue | $ 492 | $ 1,794 | ||||
| Collaboration Agreement [Member] | Maximum [Member] | ||||||
| Royalty received on sales | $ 156,000 | |||||
| X | ||||||||||
- Definition Milestone upfront payment. No definition available.
|
| X | ||||||||||
- Definition Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition For an unclassified balance sheet, amounts due from related parties including affiliates, employees, joint ventures, officers and stockholders, immediate families thereof, and pension funds. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Cash received from collaborators during the current period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|